Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Year in Review
  • Published:

Oesophageal cancer in 2014

Advances in curatively intended treatment

Nature Reviews Gastroenterology & Hepatology volume 12, pages 74–75 (2015)Cite this article

Subjects

Oesophageal cancer is characterized by poor prognosis, and curatively intended treatment is extensive and demanding. In 2014, well-designed clinical studies have advanced our knowledge of how to improve the treatment of oesophageal cancer at various tumour stages.

This is a preview of subscription content, access via your institution

Relevant articles

Open Access articles citing this article.

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

Figure 1: A surgically resected specimen of the oesophagus with Barrett mucosa and an adenocarcinoma (top) and the proximal stomach (bottom).

References

  1. Lagergren, J. & Lagergren, P. Oesophageal cancer. BMJ 341, c6280 (2010).

    Article  Google Scholar 

  2. Tomizawa, Y. et al. Safety of endoscopic mucosal resection for Barrett's esophagus. Am. J. Gastroenterol. 108, 1440–1447 (2013).

    Article  Google Scholar 

  3. Shaheen, N. J. et al. Radiofrequency ablation in Barrett's esophagus with dysplasia. N. Engl. J. Med. 360, 2277–2288 (2009).

    Article  CAS  Google Scholar 

  4. Sjoquist, K. M. et al. Survival after neoadjuvant chemotherapy or chemoradiotherapy for resectable oesophageal carcinoma: an updated meta-analysis. Lancet Oncol. 12, 681–692 (2011).

    Article  Google Scholar 

  5. van Hagen, P. et al. Preoperative chemoradiotherapy for esophageal or junctional cancer. N. Engl. J. Med. 366, 2074–2084 (2012).

    Article  CAS  Google Scholar 

  6. Phoa, K. N. et al. Radiofrequency ablation vs endoscopic surveillance for patients with Barrett esophagus and low-grade dysplasia: a randomized clinical trial. JAMA 311, 1209–1217 (2014).

    Article  CAS  Google Scholar 

  7. Merkow, R. P. et al. Treatment trends, risk of lymph node metastasis, and outcomes for localized esophageal cancer. J. Natl Cancer Inst. 106, dju133 (2014).

    Article  Google Scholar 

  8. Mariette, C. et al. Surgery alone versus chemoradiotherapy followed by surgery for stage I and II esophageal cancer: final analysis of randomized controlled phase III trial FFCD 9901. J. Clin. Oncol. 32, 2416–2422 (2014).

    Article  CAS  Google Scholar 

  9. van Meerten, E. et al. Pathological analysis after neoadjuvant chemoradiotherapy for esophageal carcinoma: the Rotterdam experience. J. Surg. Oncol. 100, 32–37 (2009).

    Article  CAS  Google Scholar 

  10. Oppedijk, V. et al. Patterns of recurrence after surgery alone versus preoperative chemoradiotherapy and surgery in the CROSS trials. J. Clin. Oncol. 32, 385–391 (2014).

    Article  Google Scholar 

Download references

Acknowledgements

The work of the author is supported by Swedish Research Council Formas (2-593/2013).

Author information

Authors and Affiliations

  1. Upper Gastrointestinal Surgery, Molecular Medicine and Surgery, NS 67, 2nd Floor, Karolinska Institutet, Stockholm, 171 76, Sweden

    Jesper Lagergren

Authors
  1. Jesper Lagergren
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Jesper Lagergren.

Ethics declarations

Competing interests

The author declares no competing financial interests.

PowerPoint slides

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Lagergren, J. Advances in curatively intended treatment. Nat Rev Gastroenterol Hepatol 12, 74–75 (2015). https://doi.org/10.1038/nrgastro.2014.213

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/nrgastro.2014.213

This article is cited by

Search

Advanced search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing